- ICH GCP
- EU Clinical Trials Registry
Latest Trials
EudraCT Number: 2006-003929-83 | Sponsor Protocol Number: ML 20469/GOIRC | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: GRUPPO ONCOLOGICO ITALIANO DI RICERCA | |||||||||||||
Full Title: Phase II study of Bevacizumab in combination with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancer. | |||||||||||||
Medical condition: Patients with advanced breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005077-29 | Sponsor Protocol Number: D4200C00058 | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: AstraZeneca AB | |||||||||||||
Full Title: An International, Phase III, Randomized, Double-Blinded, Placebo-Controlled, Multi-Center Study to Assess the Efficacy of ZD6474 (ZACTIMA ) versus Placebo in Subjects with Unresectable Locally Adva... | |||||||||||||
Medical condition: Medullary thyroid cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Ongoing) FR (Ongoing) BE (Ongoing) HU (Completed) PT (Ongoing) SE (Ongoing) DK (Completed) AT (Completed) IT (Completed) GB (Completed) CZ (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003748-43 | Sponsor Protocol Number: TKA 4 | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: Ortopædkirurgisk Center, Aarhus Universitets Hospital | |||||||||||||
Full Title: Kan topical bisfosfonat øge fiksation og overlevelse af ucementeret knæledsprotese? Et prospektivt randomiseret migrations- og knogledensitetsstudie på tibia-implantater af trabeculært metal. | |||||||||||||
Medical condition: Osteoarthritis of the knee treated with knee alloplastic | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003255-20 | Sponsor Protocol Number: CRAD001C2241 | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: NOVARTIS FARMA | |||||||||||||
Full Title: A single arm, multicenter phase II study of RAD001 in patients with metastatic colorectal adenocarcinoma whose cancer has progressed despite prior therapy with an anti-EGFR antibody (if appropriate... | |||||||||||||
Medical condition: metastatic colorectal adenocarcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000606-23 | Sponsor Protocol Number: 26756 | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: Merck, S.L. | |||||||||||||
Full Title: Post-authorization safety study to check the potential association between the safety profile of beta interferon 1a and the body mass index or pharmacodynamics during the titration phase | |||||||||||||
Medical condition: Not applicalbe | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003512-22 | Sponsor Protocol Number: 0869-130 | Start Date: 2006-11-23 | ||||||
Sponsor Name: Laboratoires Merck Sharp & Dohme-Chibret | ||||||||
Full Title: A Randomized, Double-Blind, Parallel-Group Study Conducted Under In-House Blinding Conditions to Determine the Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nau... | ||||||||
Medical condition: Chemotherapy-induced Nausea and Vomitting | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: FR (Completed) DE (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2005-003819-71 | Sponsor Protocol Number: DX-88/14 | Start Date: 2006-11-23 | ||||||
Sponsor Name: Dyax Corp | ||||||||
Full Title: EDEMA3: Evaluation of DX-88’s Effects in Mitigating Angioedema A double-blind, placebo-controlled study followed by a repeat dosing phase to assess the efficacy and safety of DX-88 (recombinant pl... | ||||||||
Medical condition: Hereditary Angioedema | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: BE (Completed) GB (Completed) IT (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001595-20 | Sponsor Protocol Number: CRAD001J2102 | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: NOVARTIS FARMA | |||||||||||||
Full Title: A phase Ib study investigating the combination of RAD001 with trastuzumab and vinorelbine in patients with HER2- overexpressing metastatic breast cancer | |||||||||||||
Medical condition: HER2 overexpressing metastatic breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002335-24 | Sponsor Protocol Number: 13362B | Start Date: 2006-11-23 | ||||||
Sponsor Name: University of Chicago | ||||||||
Full Title: A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients with N2/N3 Locally Advanced Head and Neck Cancer Estudio de fase III randomizado de una quimioterapia de inducción... | ||||||||
Medical condition: Phase III trial of induction therapy with docetaxel followed by chemoradiotherapy versus chemoradiotherapy alone in patients with nodal stage N2 or N3 head and neck cancer | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: ES (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005494-21 | Sponsor Protocol Number: MARIA | Start Date: 2006-11-23 | |||||||||||
Sponsor Name: HYKS Marian sairaala | |||||||||||||
Full Title: Hyperbaarisen artikaiini-glukoosiliuoksen ja pelkän artikaiinin vertailu spinaalipuudutuksessa nivustyräpotilailla | |||||||||||||
Medical condition: nivustyrä | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |